Category: Uncategorized

  • The political tug-of-war at the center of Trump’s Iran decision: From the Politics Desk

    The political tug-of-war at the center of Trump’s Iran decision: From the Politics Desk



    Welcome to the online version of From the Politics Desk, an evening newsletter that brings you the NBC News Politics team’s latest reporting and analysis from the White House, Capitol Hill and the campaign trail.

    In today’s edition, Andrea Mitchell breaks down the critical decision facing President Donald Trump on the Israel-Iran conflict. Plus, Lawrence Hurley examines the questions that a major Supreme Court ruling on transgender rights left unanswered.

    Programming note: We’re taking a break for Juneteenth tomorrow and will be back in your inbox on Friday, June 20.

    Sign up to receive this newsletter in your inbox every weekday here.

    — Adam Wollner


    The political tug-of-war at the center of Trump’s Iran decision

    By Andrea Mitchell

    As President Donald Trump considers whether the U.S. will strike Iran — likely the most important decision of his second term, one that could remake the landscape of the Middle East — allies and adversaries are taking sides, both at home and abroad.

    “I may do it. I may not do it,” Trump told reporters outside the White House earlier today. “Nobody knows what I’m going to do.”

    The president openly admired the effectiveness of Israel’s initial airstrikes against Iran, even though Israeli Prime Minister Benjamin Netanyahu clearly launched his strikes to interrupt Trump’s nuclear diplomacy with Tehran.

    But after being rebuffed in April when he sought Trump’s approval for a joint operation against Iran’s nuclear program, Netanyahu could be on the verge of persuading an American president to provide the B-2s to deliver the 30,000-pound “bunker buster” bombs capable of penetrating the concrete fortress believed to conceal Tehran’s most dangerous stockpile of nearly-weapons-grade uranium, based on new Israeli intelligence. Sen. Mark Warner, D-Va., the vice chair of the Senate Intelligence Committee, said on MSNBC today that conflicts with a briefing to Congress this week that the U.S. intelligence has not changed: Iran has not decided to build a nuclear weapon.

    Israel’s argument is that it’s now or never. It has decapitated two of Iran’s proxies — Hezbollah and Hamas — and toppled the Assad regime in Syria, and its retaliatory strikes last year eliminated many of Iran’s air defenses. Israel’s air force could damage Iran’s above-ground nuclear sites and missile bases if it struck now, before Iran repairs its defenses, but can’t eliminate the nuclear threat without U.S. bombs and bombers to reach the most critical underground facility.

    That has created a political tug-of-war for the heart and mind of Trump, who has publicly yearned for the Nobel Prize, seeing himself as a peacemaker who could bring Iran back into the community of non-terrorist nations and avoid another “forever war.” Fighting that vision is his competing impulse to join Israel in eliminating the nuclear threat once and for all. And Tehran’s leaders clearly misjudged how patient Trump would be with their refusal to compromise in the negotiations.

    Russian President Vladimir Putin remains on the sidelines, preoccupied with his own war. Jordan’s King Abdullah II and French President Emmanuel Macron strongly oppose U.S. involvement. Trump has been consulting Saudi Crown Prince Mohammed bin Salman, the Gulf’s most influential leader.

    At home, the MAGA base is divided, with Sen. Lindsey Graham, R-S.C., leading the hawks and a growing cohort of Republican isolationists — even in Trump’s Cabinet — opposed. Most prominently, Director of National Intelligence Tulsi Gabbard posted a highly produced anti-war video on her official X account, reportedly infuriating her boss.

    Critics worry about unintended consequences of military action, repeating former Secretary of State Colin Powell’s rueful warning before the U.S. war in Iraq. It’s like the Pottery Barn rule: If you break it, you own it.

    Catch up on our latest reporting on the Israel-Iran conflict:

    Amid escalating global tensions, Trump struggles to be a ‘peacemaker,’ by Peter Nicholas, Peter Alexander, Jonathan Allen and Dan De Luce

    U.S.-backed regime change has a checkered past — Iran may be no different, by Alexander Smith

    Will Israel’s airstrikes cause the collapse of the Iranian regime?, by Dan De Luce and Alexander Smith

    Tucker Carlson clashes with Sen. Ted Cruz: ‘You don’t know anything about Iran,’ by Megan Lebowitz

    Follow live updates →


    Supreme Court ruling on transgender youth medical care leaves broader legal questions unresolved

    By Lawrence Hurley

    The Supreme Court ruling that upheld a Tennessee law banning certain care for transgender youth left various legal questions open, even as other laws aimed at people based on gender identity, including those involving sports and military-service bans, head toward the justices.

    That means that even though transgender rights activists face a setback, the ruling does not control how other cases will ultimately turn out.

    “This decision casts little if any light on how a majority of justices will analyze or rule on other issues,” said Shannon Minter, a lawyer at the National Center for LGBTQ Rights.

    Most notably, the court, which has a 6-3 conservative majority, did not address the key issue of whether such laws should automatically be reviewed by courts with a more skeptical eye, an approach known as “heightened scrutiny.” Practically, that would mean laws about transgender people would have to clear a higher legal bar to be upheld.

    The justices skipped answering that question because the court found that Tennessee’s law banning gender transition care for minors did not discriminate against transgender people at all.

    But other cases are likely to raise that issue more directly, meaning close attention will be paid to what the justices said in the various written opinions, as well as what they did not say.

    Read more from Lawrence →


    🗞️ Today’s other top stories

    • ↔️ Holding the line: The Federal Reserve left interest rates at their current levels as the central bank continued to assess the impact of Trump’s tariffs on the U.S. economy. Read more →
    • ⚖️ SCOTUS watch: The Supreme Court rejected a challenge to the Nuclear Regulatory Commission’s authority to approve a facility in Texas to store spent fuel. Read more →
    • 💉 New sheriff in town: Health Secretary Robert F. Kennedy Jr. has ushered in appointees to a federal vaccine advisory panel who have expressed skepticism about the value and safety of vaccines. Read more →
    • 🤔 Regrets, they have a few: Most of the seven Senate Democrats who voted to confirm Kristi Noem as secretary of the Department of Homeland Security are now critical of her performance, with some saying they’d like a do-over. Read more →
    • 📊 Survey says: Americans are divided on their views of artificial intelligence, with no meaningful differences based on age and partisanship, according to the NBC News Decision Desk Poll. The country’s attitudes about AI today mirror poll answers about the rise of the internet in the ‘90s.
    • 🔵 2026 watch: Bridget Brink, the former U.S. ambassador to Ukraine, announced she is running for Congress as a Democrat for a competitive Michigan House seat that Republicans flipped in 2024. Read more →
    • 🗳️ About last night: Democratic state Sen. Ghazala Hashmi won her party’s nomination for lieutenant governor of Virginia in a tight race against a fellow state senator and a former Richmond mayor. Read more →

    That’s all From the Politics Desk for now. Today’s newsletter was compiled by Adam Wollner and Dylan Ebs.

    If you have feedback — likes or dislikes — email us at [email protected]

    And if you’re a fan, please share with everyone and anyone. They can sign up here.




    Source link

  • Apple looking to make ‘premium’ priced folding iPhones starting next year, analyst says

    Apple looking to make ‘premium’ priced folding iPhones starting next year, analyst says



    Apple has plans to make a folding iPhone starting next year, reliable analyst Ming-Chi Kuo said on Wednesday.

    Kuo said Apple’s folding phone could have a display made by Samsung Display, which is planning to produce as many as eight million foldable panels for the device next year. However, other components haven’t been finalized, including the device’s hinge, Kuo wrote. He expects it to have “premium pricing.”

    Kuo is an analyst for TF International Securities, and focuses on the Asian electronics supply chain and often discusses Apple products before they’re launched.

    He wrote in a post on social media site X that Apple’s plans for the foldable iPhone aren’t locked in yet and are subject to change. Apple did not respond to CNBC’s request for comment.

    Apple’s iPhone makes up over half of Apple’s business and remains an incredibly profitable product, accounting for $201 billion in sales in the company’s fiscal 2024. But iPhone revenue peaked in 2022, and Apple is constantly looking for ways to attract new customers and convince its current customers to upgrade to more expensive devices.

    Several of Apple’s rivals, including Huawei and Samsung, have been releasing folding smartphones since 2019.

    The devices promise the screen size of a tablet in a format that can be stored in pants pockets. But folding phones still have hardware issues, including creases in the display where it is folded.

    Folding phones also have yet to prove they drive significant demand after the novelty wears off.

    Research firm TrendForce said last year that only 1.5% of all smartphones sold can fold. Counterpoint, another research firm tracking smartphone sales, said earlier this year that the folding market only grew about 3% in 2024 and is expected to shrink in 2025.



    Source link

  • Nike pushes back Skims launch with Kim Kardashian due to production delays

    Nike pushes back Skims launch with Kim Kardashian due to production delays



    Kim Kardashian fans are going to have to wait a little longer for the highly anticipated NikeSKIMS line.

    The activewear line will launch later this year instead of in the spring, like the companies had originally announced, because of production delays, according to a person familiar with the matter who requested anonymity to speak candidly. The person added that the delays are internal and not because of a supplier or shipping issue.

    No date has been determined for the new launch date, the person added.

    The person also said the relationship with Kardashian and the brand is still strong and that everyone is on the same page, but they want to make sure they take their time and get the products right.

    Nike first announced the Skims partnership in February and said it would include apparel, footwear and accessories. Since then, Heidi O’Neill, one of the key leaders behind the partnership, has left the company.

    New Nike CEO Elliott Hill has been betting big on the Skims brand as he looks to re-invigorate the company after recent declines in sales and its business. For Skims, which was last valued at $4 billion, the partnership with Nike brings a growth opportunity as it expands into athleisure.

    Nike’s stock is down more than 20% year-to-date.

    “The origin of NikeSKIMS is rooted in a desire to bring something new and unexpected to an industry that is craving something different, and to invite a new generation of women into fitness with disruptive product designed to meet their needs in both performance and style,” the company said about the line when they introduced it.

    The news was first reported by Bloomberg.

    Nike and SKIMS collaboration featuring Kim Kardashian, Co-Founder and Chief Creative Officer, SKIMS.Courtesy: Nike Inc.



    Source link

  • DOJ seizes record $225 million in crypto tied to global ‘pig butchering’ scams

    DOJ seizes record $225 million in crypto tied to global ‘pig butchering’ scams



    The Justice Department announced Wednesday the largest-ever U.S. seizure of cryptocurrency linked to so-called “pig butchering” scams that have cost victims billions globally.

    Federal prosecutors filed a civil forfeiture action targeting more than $225 million in cryptocurrency traced to a sprawling web of fraudulent investment platforms. Victims were tricked into believing they were investing in legitimate crypto ventures, only to be scammed by criminal networks often operating overseas.

    “This seizure of $225.3 million in funds linked to cryptocurrency investment scams marks the largest cryptocurrency seizure in U.S. Secret Service history,” said Shawn Bradstreet, special agent in charge of the U.S. Secret Service’s San Francisco Field Office, in a statement.

    Authorities said the network was connected to at least 400 suspected victims worldwide, including dozens in the U.S. Crypto fraud was responsible for more than $5.8 billion in reported losses last year, according to FBI data.

    The seized funds are now subject to forfeiture proceedings aimed at eventually returning money to victims.

    The U.S. Secret Service and FBI used blockchain analysis and other tools to trace the cryptocurrency back to stolen assets. The DOJ credited Tether, the world’s largest stablecoin issuer, for assisting in the operation.

    According to the complaint, the funds were linked to the theft and laundering of money from victims of cryptocurrency investment fraud schemes, commonly known as confidence scams that often involve romance.

    The network relied on hundreds of thousands of transactions to obscure the origin of the funds, using sophisticated blockchain maneuvers to conceal the flow of stolen assets.



    Source link

  • What to know about lenacapavir

    What to know about lenacapavir



    The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among people given an injection every six months.

    Called lenacapavir, the highly effective drug has inspired feverish anticipation among advocates for HIV prevention. The hope is the medication could accelerate the stubbornly slow decline of HIV transmission in the United States.

    “This is the single best opportunity in 44 years of HIV prevention,” said Mitchell Warren, executive director of the HIV advocacy nonprofit group AVAC.

    Lenacapavir, which is given by health care workers in clinics, is significantly more effective than the existing oral HIV-prevention drugs, experts said, because it appears to address the challenges of sticking to a daily pill regimen for people who are at high risk of HIV.

    Gilead’s chairman and CEO, Daniel O’Day, suggested in a statement Wednesday that lenacapavir could “end the HIV epidemic once and for all.”

    Lenacapavir was approved after astounding results in Gilead’s large clinical trials of the drug. The trials randomly assigned people at risk of HIV to receive either lenacapavir injections every six months or daily Truvada, a pill form of pre-exposure prophylaxis, or PrEP. Among gay and bisexual men and transgender people, the lenacapavir group had an 89% lower HIV rate than a group taking Truvada and a 96% lower rate than Gilead estimated would have been expected absent any PrEP.

    In a similar trial among cisgender women in sub-Saharan Africa, no one who received lenacapavir contracted HIV.

    The drug the first in a new class of antiretrovirals which block HIV from infecting and making new copies of itself inside the immune cells it targets. Lenacapavir was first approved in 2022, under the brand name Sunleca, for use with other medications to treat highly drug resistant strains of the virus.

    All forms of PrEP work in the same way: If enough of the drug is present in the body when a person is exposed to HIV, it’s highly effective at preventing the virus from taking hold and establishing a lifelong infection. Lenacapavir is so long-acting, it only needs to be injected twice a year.

    However, lenacapavir’s use as PrEP against HIV emerges into a political climate that experts warn could derail progress against the virus’ spread. The Trump administration’s recent sweeping cancellations of research grants and its severe cuts to the Centers for Disease Control and Prevention’s staffing have dramatically affected the HIV-prevention field in particular. HIV experts are concerned that lenacapavir’s full potential might remain unrealized.

    Lenacapavir’s cost could be another hurdle if health insurance companies don’t pay for the new drug.

    Health insurers, at least in the near term, might decline to cover lenacapavir in favor of other forms of PrEP, including the cheaper generic version of Truvada pills, which cost as little as $30 per month. Or insurers might impose higher copays for lenacapavir, said Elizabeth Kaplan, director of health care access at Harvard Law School’s Health Law and Policy Clinic.

    A pending Supreme Court decision concerning a pillar of the Affordable Care Act could also be a barrier to insurance coverage for medications that prevent HIV. The ACA, or Obamacare, mandates no-cost coverage for certain preventive interventions like PrEP.

    Mixed success for PrEP drugs

    Older forms of PrEP have had mixed success.

    Truvada, also made by Gilead, was the first approved PrEP drug in 2012, followed by a similar oral medication from the company, Descovy, in 2019.

    They have steadily gained popularity among gay and bisexual men, who, according to the CDC, account for 7 in 10 new HIV cases and comprise the overwhelming share of PrEP users.

    However, considering how much higher the HIV rate is among Black and Latino gay men compared with their white peers, PrEP use among men of color has remained disproportionately low. Experts believe PrEP has most likely hastened HIV’s considerable decline among white gay and bisexual men, but the HIV rate among Black and Latino gay and bisexual men has persisted at markedly high rates. In addition, when they are prescribed PrEP, Black gay men are less likely to take the pill regimen as prescribed.

    When they are taken daily, Truvada and Descovy each slash HIV risk by at least 99%. But inconsistent use diminishes PrEP’s effectiveness.

    In late 2021, ViiV Healthcare’s Apretude was approved as an injectable PrEP given every two months.

    Despite being much more effective than Truvada at lowering HIV cases across a population of gay and bisexual men and transgender women in a major clinical trial, Apretude has gained scant traction until recently. About 21,000 people are taking it, ViiV reported. It’s possible that, in part, people have been alienated by the requirement to visit a clinic every two months for Apretude, instead of every three months for an oral PrEP prescription.

    Lenacapavir has the potential, but will it deliver?

    Lenacapavir offers an alternative for people who won’t or have trouble remembering to take a pill every day, and it reduces the number of required annual clinic visits from four to two.

    According to CDC estimates, during the decade after PrEP’s debut, the annual HIV transmission rate declined by only 17%, from 38,300 cases in 2012 to 31,800 cases in 2022. Much of the decline occurred since 2018, with case numbers falling by 12% during that four-year period.

    In 2019, the Trump administration launched the Ending the HIV Epidemic, or EHE, initiative, which has since targeted nearly $3 billion in new spending to combat HIV, including by promoting PrEP, in 48 hot-spot counties in particular. The target jurisdictions had a swifter 21% decline in estimated HIV transmissions from 2018 to 2022.

    In a study published in October, CDC investigators reported that PrEP use has risen steadily since 2014 and that about 200,000 people were receiving some form of it during any month of 2023.

    But that is only a small fraction of the 1.5 million gay and bisexual men who are good PrEP candidates, according to estimates in a new CDC study published in May.

    The crucial question is whether a critical mass of people who otherwise wouldn’t have stuck to an oral PrEP regimen can routinely be provided lenacapavir while they are at risk of HIV.

    Dr. Susanne Doblecki-Lewis, chief of the division of infectious diseases at the University of Miami Miller School of Medicine, is the site principal investigator for the lenacapavir clinical trial in gay men and a separate trial in people who inject drugs. She said lenacapavir could mitigate HIV-related racial disparities, provided it is made “available easily and at low or no cost to people who can benefit from it who are uninsured or underinsured.”

    But, she said, “if there are barriers, like complicated prior authorizations or high copays that will prevent people from easily starting it, we could see disparities just get worse.”

    Political challenges

    The Trump administration’s 2026 budget request seeks a $1.5 billion, or 35%, cut for domestic HIV funding. That includes shuttering the CDC’s $794 million HIV-prevention division, although some remnants of it are apparently meant to be folded into a new federal health department, along with a maintained $220 million in EHE funding.

    Much of the CDC’s HIV-prevention and -surveillance budget is distributed in grants to state and local health departments and nonprofit organizations. Severe federal budget cuts would most likely hobble those entities’ efforts to educate at-risk populations and doctors about lenacapavir and provide services to facilitate its use.

    Another hurdle for prescribers is whether they can ensure that people at risk of HIV return for lenacapavir shots twice yearly. Two recent studies, one published in May and another presented at a conference in March, found that fewer than half of oral PrEP users stay on it for six months or longer.

    Historically, the National Institutes of Health has funded research to help implement new forms of PrEP, examining weak spots and devising interventions. But the Trump administration’s campaign to slash NIH spending has had a severe impact on HIV research, including PrEP, according to a dossier of canceled grants compiled by a Harvard researcher.

    A federal judge ruled Monday that some such NIH grant terminations were “arbitrary and capricious” and “void and illegal.” But the temporary win for researchers doesn’t mean the NIH under Trump will necessarily become newly hospitable to grant proposals concerning PrEP implementation.

    Johanna Mercier, Gilead’s chief commercial officer, said in an interview this month that the company has been pushing insurers to cover lenacapavir. She expressed optimism for ultimately widespread coverage of the drug.

    Gilead will cover up to $7,200 annually in out-of-pocket costs for insured people receiving lenacapavir. And its patient assistance program will provide it free to low-income uninsured people. There is otherwise a patchwork system nationally that can often aid the uninsured in covering the required clinic visits and lab tests.

    Tristan Schukraft, CEO of the popular PrEP-focused telehealth company Mistr, said it intends to begin offering lenacapavir immediately through its storefronts in seven major urban gay neighborhoods. The company has also formed partnerships with a nationwide network of community-based clinics that can provide the shots, including to people without insurance.

    “We’re ready,” Schukraft said.



    Source link

  • Ex-Raiders receiver Henry Ruggs apologizes to car crash victim’s family

    Ex-Raiders receiver Henry Ruggs apologizes to car crash victim’s family



    Former Las Vegas Raiders wide receiver Henry Ruggs III said he wishes he could “turn back the hands of time” while speaking at an event Tuesday about his role in a 2021 car crash that left a woman dead.

    Ruggs, 26, was granted special release from prison to speak at a Hope For Prisoners event, the group said in a Facebook post.

    He was sentenced to three to 10 years after he pleaded guilty in 2023 to a felony count of DUI resulting in death and misdemeanor manslaughter. The crash was the result of drunk driving and speeding and killed 23-year-old Tina Tintor.

    “It’s an unfortunate situation that I’m sure we all wish we can make some choices again and turn back the hands of time,” he said in a livestream of the event. “I never saw myself in that type of situation.”

    Ruggs said he never planned on driving that night.

    Police said Ruggs was driving his Corvette at 156 mph while drunk when he crashed into Tintor’s vehicle on Nov. 2, 2021. She died of thermal injuries after the car caught fire, the medical examiner’s office said. Her dog also died in the crash.

    When asked what he would say to Tintor’s family, Ruggs responded: “I would love for them to meet the real Henry Ruggs and not the one that was escaping from something.”

    “I sincerely apologize for not only being a part of that situation, but the fact that my face is always in the news, my face is always in the newspaper, so they have to constantly be reminded of the situation,” he continued.

    The former NFL athlete, who attended the University of Alabama, was drafted by the Raiders in 2020, but was dropped from the team hours after the crash. Ruggs said he would love the opportunity to play football again and would be open to returning to the Raiders.

    “I would love to come and go out gracefully,” he said. “I don’t feel like I ended on the terms that are meaningful to me and that I value.”



    Source link

  • North Dakota man charged with threatening officials in emails that cited MN lawmaker shootings

    North Dakota man charged with threatening officials in emails that cited MN lawmaker shootings



    A North Dakota man has been charged after he allegedly emailed violent threats to a federal prosecutor and cited the weekend fatal shooting of Minnesota state Rep. Melissa Hortman and her husband.

    Charles Dalzell, a 46-year-old from St. Thomas, was arrested on Monday by FBI agents and charged with interstate threats and threats against a federal officials. It’s not immediately clear if he’s retained an attorney.

    According to the federal criminal complaint, Dalzell had allegedly sent an email Sunday evening via an obscure address to a “J.P.” of the United States Attorney’s Office for the District of North Dakota. The filing didn’t identify J.P. by name.

    The email, which identified Dalzell as the sender, referred to the deadly shootings of Hortman and her husband, the complaint states.

    “Now I’m going to be honest with you I don’t want this situation to end up like Minnesota over the weekend, do you,” the email said, according to the complaint. “I’m trying to get all of you to actually follow the law, not ignore me, not lie to me, not mislead me and purposely waist (sic) my time I don’t have.”

    “That is what you all have done and this makes me wonder if these bad situations are really what you want or do you hope that I flip out and end up dead by a police officer?” the email added, the complaint states.

    Hortman, 55, and her husband, Mark Hortman, were fatally shot at their Brooklyn Park, Minnesota, home early Saturday morning in what authorities have called a politically motivated attack. In that case, the shooting suspect had first opened fire upon state Sen. John Hoffman and his wife, Yvette Hoffman, and went to the homes of other state politicians.

    The Sunday email indicated that Dalzell was allegedly owed money after a court victory. According to the complaint, he claimed he raised concerns regarding his legal case to federally elected public officials but was ignored, and police “were attempting to silence him so public officials could engage in corruption

    The complaint said Dalzell indicated two officers told him the public officials were not interested in helping him, and he was close to going to jail.

    “Dalzell blamed J.P., among others, for lying to him,” the complaint said.

    “Just sitting here wondering what a law maker and a representative were shot and one dead over in Minnesota and one thing comes to mind, something like that doesn’t fall out of the sky now does it … I’m most certainly not making threats but when law makers make laws and the state doesn’t follow the laws they created it would probably piss some people off right…” the email said, according to the complaint.

    The email allegedly went on to say: “I don’t know the specifics in this Minnesota case, but a representative and a lawmaker were shot and one of them is dead and all of you mentioned above are basically avoiding your responsibility and that is creating some bad situations.”

    “I’m done with you ignoring me, I’m done with the threats of jail and charges … this had god dam better get fixed Monday morning which is tomorrow because I want to avoid anymore problems and don’t want North Dakota to end up like Minnesota and no that is not a threat [J.P.] it’s a fact and a statement,” the email added, according the complaint.

    Dalzell allegedly named two public officials and a judge, whom he claimed were not effectively performing their duties. He continued by saying he would not back down “until [he’s] reimbursed,” the complaint said.

    The criminal complaint noted that the same email address was investigated for an email threat against the U.S. Attorney’s Office for the District of North Dakota back on Feb. 26, 2024.

    In that case, the email listed the sender as “Chuck Miller,” and the writer described undergoing a legal challenge.

    That email said, “I’m on the very very edge of flipping the fuck out.” It went on to ask for help “before I lose control.”

    Dalzell allegedly then appeared to threaten violence.

    “I am not asking for help I am demanding it because honestly person to person this is going to turn bad as I am completely surrounded and there’s a word that starts with a V and ends with a T and kinda sounds like violin and that is where this is heading if I don’t get some help,” the email said, according to the complaint.

    That day of the February email, the FBI interviewed Dalzell at a residence in St. Thomas. The complaint states that he was confronted with the email alluding to violence and told the FBI he sent that to the state and said he wanted help with his property legal situation.

    Dalzell told the FBI that “if he wanted to go shoot a place up he would not advertise it. He told law enforcement that he does not have access to firearms,” the complaint states.

    Dalzell is due in court for his first appearance at 5 p.m. ET.



    Source link

  • DHS Secretary Kristi Noem taken to hospital after an allergic reaction

    DHS Secretary Kristi Noem taken to hospital after an allergic reaction



    Homeland Security Secretary Kristi Noem was taken to the hospital on Tuesday after she suffered an allergic reaction.

    “Secretary Noem had an allergic reaction. She was transported to the hospital out of an abundance of caution. She is alert and recovering,” Department of Homeland Security spokeswoman Tricia McLaughlin said in a statement.

    A DHS official told NBC News that Noem was at Joint Base Anacostia-Bolling in Washington when she had the allergic reaction.

    Noem had a scheduled press conference Wednesday morning, but it was postponed.

    DHS did not immediately respond to a request for comment on Wednesday.



    Source link

  • Man arrested after Pennsylvania teen missing for nearly a year found alive in North Carolina

    Man arrested after Pennsylvania teen missing for nearly a year found alive in North Carolina



    A 32-year-old man was arrested on multiple charges after a Pennsylvania teenage girl who was reported missing nearly a year ago was found alive at his North Carolina home, authorities said.

    Police in High Point located the 15-year-old victim on Monday afternoon after receiving information that she may have been living in the Treyburn Lane home, the department said in a Facebook post.

    The girl was reported missing from Reading, Pennsylvania, in June 2024, court documents state. The Reading Police Department did not immediately respond to a request for comment.

    Joseph A. Rossomando was arrested after authorities executed a search warrant at the home and found that he was in possession of child sexual abuse material, the news release states.

    He was booked at the Guilford County Jail on charges of statutory sex offense with a child under the age of 15, statutory rape of a child under the age of 15, felony human trafficking of a child victim, felony sexual servitude of a child victim, felony second degree sexual exploitation of a minor, felony statutory rape, felony first degree kidnapping, and contributing to the delinquency of a minor.

    Neighbors told NBC affiliate WXII-TV of Winston-Salem that they were shocked.

    “It makes you want to get to know your neighbors a little better just to protect each other and be on the lookout for stuff like that,” one neighbor said.

    “It’s shocking, it’s disturbing. Again, it just makes you want to know more about what’s going on around you,” the neighbor said.



    Source link

  • Pioneers of AI Warns Technology Could Pose Threat to Workforce

    Pioneers of AI Warns Technology Could Pose Threat to Workforce


    IE 11 is not supported. For an optimal experience visit our site on another browser.

    • Now Playing

      Could the Rise of Artificial Intelligence Soon Threaten Your Job?

      04:03

    • UP NEXT

      New Warning About Hitting ‘Unsubscribe’ on Unwanted Emails

      04:11

    • TODAY’s Bestsellers: Shop These Fan-Favorite Items for Summer

      04:07

    • Gamers Line Up for Nintendo Switch 2 as Massive Hype Builds

      03:38

    • 2002: William Shatner on Real-Life Technology Inspired by ‘Star Trek’

      04:32

    • Coolest new tech for summer: Smart glasses, JBL speaker, more

      04:32

    • Poll finds nearly half of teens see social media as mostly negative

      03:53

    • Price-tracking tools to maximize purchases (and minimize costs)

      03:57

    • Trump extends TikTok deal deadline by 75 days amid tariff turmoil

      01:37

    • Get an exclusive look inside Xbox’s top secret gaming labs

      04:01

    • Refresh your daily beauty routine with these eco-friendly products

      03:41

    • Al Roker’s image used in new deepfake scam: What to know

      04:55

    • If 23andMe is sold, what happens to everyone’s data?

      02:32

    • Bobbie’s Bests: Shop these beauty breakthroughs

      03:26

    • DNA testing company 23andMe files for bankruptcy protection

      00:27

    • How humans are forming romantic relationships with AI chatbots

      04:11

    • Elon Musk claims X outage caused by ‘massive cyberattack’

      00:24

    • Facebook whistleblower alleges ‘lethal carelessness’ in new book

      04:20

    • Easy and affordable upgrades to create a smart home

      04:54

    • How to protect your privacy from tech that tracks you

      05:01

    Pioneers of artificial intelligence, including Geoffrey Hinton, considered the Godfather of AI, are warning that the technology could pose a threat to workers across nearly every sector. Hinton says that without reforms in how AI is developed and implemented, there could be sharp increases in unemployment and wealth inequality. NBC’s Savannah Sellers reports for TODAY.



Source link